{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T05:03:04Z","timestamp":1775624584178,"version":"3.50.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:00:00Z","timestamp":1689552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:00:00Z","timestamp":1689552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"European Social Fund and Plan Propio of I+D+I of UCLM","award":["2022-PRED-20649"],"award-info":[{"award-number":["2022-PRED-20649"]}]},{"DOI":"10.13039\/501100004837","name":"MCIN","doi-asserted-by":"crossref","award":["PID2021-122222OB-I00"],"award-info":[{"award-number":["PID2021-122222OB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007480","name":"Universidad de Castilla-La Mancha","doi-asserted-by":"publisher","award":["2019-GRIN-27183"],"award-info":[{"award-number":["2019-GRIN-27183"]}],"id":[{"id":"10.13039\/501100007480","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007480","name":"Universidad de Castilla-La Mancha","doi-asserted-by":"publisher","award":["2020-GRIN-29093"],"award-info":[{"award-number":["2020-GRIN-29093"]}],"id":[{"id":"10.13039\/501100007480","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007480","name":"Universidad de Castilla-La Mancha","doi-asserted-by":"publisher","award":["2021-GRIN-311"],"award-info":[{"award-number":["2021-GRIN-311"]}],"id":[{"id":"10.13039\/501100007480","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Spanish Ministerio de Ciencia, Innovaci\u00f3n y Universidades","award":["PID2021-127187OB-C21"],"award-info":[{"award-number":["PID2021-127187OB-C21"]}]},{"DOI":"10.13039\/501100011698","name":"Junta de Comunidades de Castilla-La Mancha","doi-asserted-by":"publisher","award":["SBPLY\/19\/180501\/000191"],"award-info":[{"award-number":["SBPLY\/19\/180501\/000191"]}],"id":[{"id":"10.13039\/501100011698","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011698","name":"Junta de Comunidades de Castilla-La Mancha","doi-asserted-by":"publisher","award":["SBPLY\/19\/180501\/000251"],"award-info":[{"award-number":["SBPLY\/19\/180501\/000251"]}],"id":[{"id":"10.13039\/501100011698","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011698","name":"Junta de Comunidades de Castilla-La Mancha","doi-asserted-by":"publisher","award":["SBPLY\/19\/180501\/000260"],"award-info":[{"award-number":["SBPLY\/19\/180501\/000260"]}],"id":[{"id":"10.13039\/501100011698","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fundaci\u00f3n Leticia Castillejo Castillo","award":["2021-AYUDA-32401"],"award-info":[{"award-number":["2021-AYUDA-32401"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biol Inorg Chem"],"DOI":"10.1007\/s00775-023-02006-0","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T09:01:48Z","timestamp":1689584508000},"page":"531-547","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Ferrozoles: Ferrocenyl derivatives of letrozole with dual effects as potent aromatase inhibitors and cytostatic agents"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4364-7376","authenticated-orcid":false,"given":"Borja","family":"Diaz de Gre\u00f1u","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2699-7374","authenticated-orcid":false,"given":"Diego M.","family":"Fern\u00e1ndez-Aroca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3934-3038","authenticated-orcid":false,"given":"Juan A.","family":"Organero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5053-640X","authenticated-orcid":false,"given":"Gema","family":"Dur\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6622-044X","authenticated-orcid":false,"given":"Felix Angel","family":"Jal\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0882-9780","authenticated-orcid":false,"given":"Ricardo","family":"S\u00e1nchez-Prieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2508-8398","authenticated-orcid":false,"given":"M. Jos\u00e9","family":"Ruiz-Hidalgo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7122-1431","authenticated-orcid":false,"given":"Ana Mar\u00eda","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6942-1589","authenticated-orcid":false,"given":"Lucia","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9927-5076","authenticated-orcid":false,"given":"Jos\u00e9 L.","family":"Albasanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4908-4503","authenticated-orcid":false,"given":"Blanca R.","family":"Manzano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,17]]},"reference":[{"key":"2006_CR1","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/aps.2014.51","volume":"35","author":"J Jin-zi","year":"2014","unstructured":"Jin-zi J, Ke-jing L, Jie H et al (2014) Discovery of novel aromatase inhibitors using a homogeneous time-resolved fluorescence assay. Acta Pharmacol Sin 35:1082\u20131092. https:\/\/doi.org\/10.1038\/aps.2014.51","journal-title":"Acta Pharmacol Sin"},{"key":"2006_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MD.0000000000017559","volume":"98","author":"H Chen","year":"2019","unstructured":"Chen H, Yan M, Shi W et al (2019) Expression of estrogen receptor beta and overall survival in non-small cell lung cancer patients: protocol for a systematic review and meta-analysis of cohort studies. Med (United States) 98:1\u20134. https:\/\/doi.org\/10.1097\/MD.0000000000017559","journal-title":"Med (United States)"},{"key":"2006_CR3","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.2174\/1871520622666220426112435","volume":"22","author":"BA Rahal","year":"2022","unstructured":"Rahal BA, Bardaweel SK (2022) Implications and efficacy of aromatase inhibitors in combination and monotherapy for the treatment of lung cancer. Anticancer Agents Med Chem 22:3114\u20133124. https:\/\/doi.org\/10.2174\/1871520622666220426112435","journal-title":"Anticancer Agents Med Chem"},{"key":"2006_CR4","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.3390\/cancers12061647","volume":"12","author":"SP Langdon","year":"2020","unstructured":"Langdon SP, Herrington CS, Hollis RL, Gourley C (2020) Estrogen signaling and its potential as a target for therapy in ovarian cancer. Cancers (Basel) 12:1647. https:\/\/doi.org\/10.3390\/cancers12061647. (17 pages)","journal-title":"Cancers (Basel)"},{"key":"2006_CR5","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.ctrv.2012.07.006","volume":"39","author":"R Sainsbury","year":"2013","unstructured":"Sainsbury R (2013) The development of endocrine therapy for women with breast cancer. Cancer Treat Rev 39:507\u2013517. https:\/\/doi.org\/10.1016\/j.ctrv.2012.07.006","journal-title":"Cancer Treat Rev"},{"key":"2006_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jsbmb.2009.11.010","volume":"118","author":"Y Hong","year":"2010","unstructured":"Hong Y, Li H, Yuan YC, Chen S (2010) Sequence-function correlation of aromatase and its interaction with reductase. J Steroid Biochem Mol Biol 118:203\u2013206. https:\/\/doi.org\/10.1016\/j.jsbmb.2009.11.010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2006_CR7","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1210\/er.2004-0015","volume":"26","author":"RW Brueggemeier","year":"2005","unstructured":"Brueggemeier RW, Hackett JC, Diaz-Cruz ES (2005) Aromatase inhibitors in the treatment of breast cancer. Endocr Rev 26:331\u2013345. https:\/\/doi.org\/10.1210\/er.2004-0015","journal-title":"Endocr Rev"},{"key":"2006_CR8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1210\/er.2008-0016","volume":"30","author":"RJ Santen","year":"2009","unstructured":"Santen RJ, Brodie H, Simpson ER et al (2009) History of aromatase: Saga of an important biological mediator and therapeutic target. Endocr Rev 30:343\u2013375. https:\/\/doi.org\/10.1210\/er.2008-0016","journal-title":"Endocr Rev"},{"key":"2006_CR9","first-page":"2620","volume":"7","author":"A Buzdar","year":"2001","unstructured":"Buzdar A, Howell A (2001) Advances in aromatase inhibition: Clinical efficacy and tolerability in the treatment of breast cancer. Clin Cancer Res 7:2620\u20132635","journal-title":"Clin Cancer Res"},{"key":"2006_CR10","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ejmech.2015.08.010","volume":"102","author":"I Ahmad","year":"2015","unstructured":"Ahmad I, Shagufta, (2015) Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer. Eur J Med Chem 102:375\u2013386. https:\/\/doi.org\/10.1016\/j.ejmech.2015.08.010","journal-title":"Eur J Med Chem"},{"key":"2006_CR11","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1517\/14656566.7.14.1919","volume":"7","author":"RW Brueggemeier","year":"2006","unstructured":"Brueggemeier RW (2006) Update on the use of aromatase inhibitors in breast cancer. Expert Opin Pharmacother 7:1919\u20131930. https:\/\/doi.org\/10.1517\/14656566.7.14.1919","journal-title":"Expert Opin Pharmacother"},{"key":"2006_CR12","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1517\/14656560902953738","volume":"10","author":"JM Nabholtz","year":"2009","unstructured":"Nabholtz JM, Mouret-Reynier MA, Durando X et al (2009) Comparative review of anastrozole, letrozole and exemestane in the management of early breast cancer. Expert Opin Pharmacother 10:1435\u20131447. https:\/\/doi.org\/10.1517\/14656560902953738","journal-title":"Expert Opin Pharmacother"},{"key":"2006_CR13","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1200\/JCO.2001.19.10.2596","volume":"19","author":"H Mouridsen","year":"2001","unstructured":"Mouridsen H, Gershanovich M, Sun Y et al (2001) Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: Results of a phase III study of the international letrozole breast cancer group. J Clin Oncol 19:2596\u20132606. https:\/\/doi.org\/10.1200\/JCO.2001.19.10.2596","journal-title":"J Clin Oncol"},{"key":"2006_CR14","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1634\/theoncologist.9-2-126","volume":"9","author":"SM Campos","year":"2004","unstructured":"Campos SM (2004) Aromatase inhibitors for breast cancer in postmenopausal women. Oncologist 9:126\u2013136. https:\/\/doi.org\/10.1634\/theoncologist.9-2-126","journal-title":"Oncologist"},{"key":"2006_CR15","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/0960-0760(93)90245-R","volume":"44","author":"M Lang","year":"1993","unstructured":"Lang M, Batzl C, Furet P et al (1993) Structure-activity relationships and binding model of novel aromatase inhibitors. J Steroid Biochem Mol Biol 44:421\u2013428. https:\/\/doi.org\/10.1016\/0960-0760(93)90245-R","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2006_CR16","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/0960-0760(90)90460-3","volume":"37","author":"AS Bhatnagar","year":"1990","unstructured":"Bhatnagar AS, H\u00e4usler A, Schieweck K et al (1990) Highly selective inhibition of estrogen biosynthesis by CGS 20267, a new non-steroidal aromatase inhibitor. J Steroid Biochem Molec Biol 37:1021\u20131027. https:\/\/doi.org\/10.1016\/0960-0760(90)90460-3","journal-title":"J Steroid Biochem Molec Biol"},{"key":"2006_CR17","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/bjc.2011.58","volume":"104","author":"J Geisler","year":"2011","unstructured":"Geisler J (2011) Differences between the non-steroidal aromatase inhibitors anastrozole and letrozole- of clinical importance. Br J Cancer 104:1059\u20131066. https:\/\/doi.org\/10.1038\/bjc.2011.58","journal-title":"Br J Cancer"},{"key":"2006_CR18","doi-asserted-by":"publisher","first-page":"R183","DOI":"10.1530\/ERC-13-0099","volume":"20","author":"PE L\u00f8ning","year":"2013","unstructured":"L\u00f8ning PE, Eikesdal HP (2013) Aromatase inhibition 2013: Clinical state of the art and questions that remain to be solved. Endocr Relat Cancer 20:R183\u2013R201. https:\/\/doi.org\/10.1530\/ERC-13-0099","journal-title":"Endocr Relat Cancer"},{"key":"2006_CR19","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2018.19323","volume":"321","author":"AG Waks","year":"2019","unstructured":"Waks AG, Wines EP (2019) Breast cancer treatment: a review. J Am Med Assoc 321:288\u2013300","journal-title":"J Am Med Assoc"},{"key":"2006_CR20","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1158\/1538-7445.AM2011-1733","volume":"71","author":"VA Cortez","year":"2011","unstructured":"Cortez VA, Suzuki T, Miyat N et al (2011) Abstract 1733: therapeutic significance of ER\u03b1\u2014PELP1 axis in blocking endocrine therapy resistance. Cancer Res 71:1733. https:\/\/doi.org\/10.1158\/1538-7445.AM2011-1733","journal-title":"Cancer Res"},{"key":"2006_CR21","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1016\/j.ejmech.2011.05.074","volume":"46","author":"J Doiron","year":"2011","unstructured":"Doiron J, Soultan AH, Richard R et al (2011) Synthesis and structure-activity relationship of 1- and 2-substituted-1,2,3-triazole letrozole-based analogues as aromatase inhibitors. Eur J Med Chem 46:4010\u20134024. https:\/\/doi.org\/10.1016\/j.ejmech.2011.05.074","journal-title":"Eur J Med Chem"},{"key":"2006_CR22","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/cmdc.201300015","volume":"8","author":"LWL Woo","year":"2013","unstructured":"Woo LWL, Wood PM, Bubert C et al (2013) Synthesis and structure-activity relationship studies of derivatives of the dual aromatase-sulfatase inhibitor 4-{[(4-Cyanophenyl)(4H\u20131,2,4-triazol-4-yl)amino]methyl}phenyl sulfamate. ChemMedChem 8:779\u2013799. https:\/\/doi.org\/10.1002\/cmdc.201300015","journal-title":"ChemMedChem"},{"key":"2006_CR23","doi-asserted-by":"publisher","first-page":"4723","DOI":"10.1016\/j.bmc.2016.08.014","volume":"24","author":"Z Song","year":"2016","unstructured":"Song Z, Liu Y, Dai Z et al (2016) Synthesis and aromatase inhibitory evaluation of 4-N-nitrophenyl substituted amino-4H-1,2,4-triazole derivatives. Bioorganic Med Chem 24:4723\u20134730. https:\/\/doi.org\/10.1016\/j.bmc.2016.08.014","journal-title":"Bioorganic Med Chem"},{"key":"2006_CR24","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.1021\/jm800168s","volume":"51","author":"PM Wood","year":"2008","unstructured":"Wood PM, Woo LWL, Labrosse JR et al (2008) Chiral aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole template: synthesis, absolute configuration, and in vitro activity. J Med Chem 51:4226\u20134238. https:\/\/doi.org\/10.1021\/jm800168s","journal-title":"J Med Chem"},{"key":"2006_CR25","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.bmcl.2005.11.099","volume":"16","author":"MP L\u00e9z\u00e9","year":"2006","unstructured":"L\u00e9z\u00e9 MP, Le Borgne M, Pinson P et al (2006) Synthesis and biological evaluation of 5-[(aryl)(1H-imidazol-1-yl)methyl]- 1H-indoles: potent and selective aromatase inhibitors. Bioorganic Med Chem Lett 16:1134\u20131137. https:\/\/doi.org\/10.1016\/j.bmcl.2005.11.099","journal-title":"Bioorganic Med Chem Lett"},{"key":"2006_CR26","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.14233\/ajchem.2014.16016","volume":"26","author":"Y Dai","year":"2014","unstructured":"Dai Y, Xiao Y, Wang Q et al (2014) Syntheses and QSAR studies of benzylimidazole derivatives and benzylcarbazole as potential aromatase inhibitors. Asian J Chem 26:2381\u20132388","journal-title":"Asian J Chem"},{"key":"2006_CR27","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.ejmech.2017.11.057","volume":"143","author":"H Kang","year":"2018","unstructured":"Kang H, Xiao X, Huang C et al (2018) Potent aromatase inhibitors and molecular mechanism of inhibitory action. Eur J Med Chem 143:426\u2013437. https:\/\/doi.org\/10.1016\/j.ejmech.2017.11.057","journal-title":"Eur J Med Chem"},{"key":"2006_CR28","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.2174\/1871520618666180116105858","volume":"18","author":"F Kalalinia","year":"2018","unstructured":"Kalalinia F, Jouya M, Komachali AK et al (2018) Design, synthesis, and biological evaluation of new azole derivatives as potent aromatase inhibitors with potential effects against breast cancer. Anticancer Agents Med Chem 18:1016\u20131024. https:\/\/doi.org\/10.2174\/1871520618666180116105858","journal-title":"Anticancer Agents Med Chem"},{"key":"2006_CR29","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/j.bmcl.2013.01.045","volume":"23","author":"R Wang","year":"2013","unstructured":"Wang R, Shi HF, Zhao JF et al (2013) Design, synthesis and aromatase inhibitory activities of novel indole-imidazole derivatives. Bioorganic Med Chem Lett 23:1760\u20131762. https:\/\/doi.org\/10.1016\/j.bmcl.2013.01.045","journal-title":"Bioorganic Med Chem Lett"},{"key":"2006_CR30","doi-asserted-by":"publisher","first-page":"4713","DOI":"10.1016\/j.bmcl.2008.06.094","volume":"18","author":"MP L\u00e9z\u00e9","year":"2008","unstructured":"L\u00e9z\u00e9 MP, Palusczak A, Hartmann RW, Le Borgne M (2008) Synthesis of 6- or 4-functionalized indoles via a reductive cyclization approach and evaluation as aromatase inhibitors. Bioorganic Med Chem Lett 18:4713\u20134715. https:\/\/doi.org\/10.1016\/j.bmcl.2008.06.094","journal-title":"Bioorganic Med Chem Lett"},{"key":"2006_CR31","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0014-827X(99)00018-X","volume":"54","author":"M Pedini","year":"1999","unstructured":"Pedini M, Alunni Bistocchi G, De Meo G et al (1999) New heterocyclic derivatives of benzimidazole with germicidal activity: part XIII. In vitro aromatase inhibitory activity; preliminary observations. Farmaco 54:327\u2013330. https:\/\/doi.org\/10.1016\/S0014-827X(99)00018-X","journal-title":"Farmaco"},{"key":"2006_CR32","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1248\/cpb.48.1778","volume":"48","author":"M Toshiyuki","year":"2000","unstructured":"Toshiyuki M, Kato M, Sasahara H et al (2000) Synthesis and antitumor activity of benzimidazolyl-1,3,5-triazine and benzimidazolylpyrimidine derivatives. Chem Pharm Bull 48:1778\u20131781","journal-title":"Chem Pharm Bull"},{"key":"2006_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202000008","volume":"353","author":"U Acar \u00c7evik","year":"2020","unstructured":"Acar \u00c7evik U, Sa\u011fl\u0131k BN, Osmaniye D et al (2020) Synthesis and docking study of benzimidazole\u2013triazolothiadiazine hybrids as aromatase inhibitors. Arch Pharm (Weinheim) 353:e2000008. https:\/\/doi.org\/10.1002\/ardp.202000008","journal-title":"Arch Pharm (Weinheim)"},{"key":"2006_CR34","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1515\/znc-2020-0104","volume":"75","author":"BN Sa\u011fl\u0131k","year":"2020","unstructured":"Sa\u011fl\u0131k BN, \u015een AM, Evren AE et al (2020) Synthesis, investigation of biological effects and in silico studies of new benzimidazole derivatives as aromatase inhibitors. Z Naturforsch C J Biosci 75:353\u2013362. https:\/\/doi.org\/10.1515\/znc-2020-0104","journal-title":"Z Naturforsch C J Biosci"},{"key":"2006_CR35","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1016\/j.bmcl.2016.04.078","volume":"26","author":"M Di Matteo","year":"2016","unstructured":"Di Matteo M, Ammazzalorso A, Andreoli F et al (2016) Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors. Bioorganic Med Chem Lett 26:3192\u20133194. https:\/\/doi.org\/10.1016\/j.bmcl.2016.04.078","journal-title":"Bioorganic Med Chem Lett"},{"key":"2006_CR36","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.bioorg.2004.06.008","volume":"32","author":"C Pouget","year":"2004","unstructured":"Pouget C, Yahiaoui S, Fagnere C et al (2004) Synthesis and biological evaluation of 4-imidazolylflavans as nonsteroidal aromatase inhibitors. Bioorg Chem 32:494\u2013503. https:\/\/doi.org\/10.1016\/j.bioorg.2004.06.008","journal-title":"Bioorg Chem"},{"key":"2006_CR37","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1016\/j.ejmech.2011.03.043","volume":"46","author":"S Yahiaoui","year":"2011","unstructured":"Yahiaoui S, Pouget C, Buxeraud J et al (2011) Lead optimization of 4-imidazolylflavans: New promising aromatase inhibitors. Eur J Med Chem 46:2541\u20132545. https:\/\/doi.org\/10.1016\/j.ejmech.2011.03.043","journal-title":"Eur J Med Chem"},{"key":"2006_CR38","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1016\/j.bmcl.2004.07.090","volume":"14","author":"S Yahiaoui","year":"2004","unstructured":"Yahiaoui S, Pouget C, Fagnere C et al (2004) Synthesis and evaluation of 4-triazolylflavans as new aromatase inhibitors. Bioorganic Med Chem Lett 14:5215\u20135218. https:\/\/doi.org\/10.1016\/j.bmcl.2004.07.090","journal-title":"Bioorganic Med Chem Lett"},{"key":"2006_CR39","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1002\/cmdc.201100145","volume":"6","author":"PM Wood","year":"2011","unstructured":"Wood PM, Woo LWL, Thomas MP et al (2011) Aromatase and dual aromatase-steroid sulfatase inhibitors from the letrozole and vorozole templates. ChemMedChem 6:1423\u20131438. https:\/\/doi.org\/10.1002\/cmdc.201100145","journal-title":"ChemMedChem"},{"key":"2006_CR40","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1021\/ml100273k","volume":"2","author":"LWL Woo","year":"2011","unstructured":"Woo LWL, Bubert C, Purohit A, Potter BVL (2011) Hybrid dual aromatase-steroid sulfatase inhibitors with exquisite picomolar inhibitory activity. ACS Med Chem Lett 2:243\u2013247. https:\/\/doi.org\/10.1021\/ml100273k","journal-title":"ACS Med Chem Lett"},{"key":"2006_CR41","doi-asserted-by":"publisher","first-page":"S159","DOI":"10.1007\/s12210-016-0565-z","volume":"28","author":"G Gilardi","year":"2017","unstructured":"Gilardi G, Di Nardo G (2017) Heme iron centers in cytochrome P450: structure and catalytic activity. Rend Lincei 28:S159\u2013S167. https:\/\/doi.org\/10.1007\/s12210-016-0565-z","journal-title":"Rend Lincei"},{"key":"2006_CR42","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1139\/cjc-2017-0419","volume":"95","author":"N Adhikari","year":"2017","unstructured":"Adhikari N, Amin SA, Jha T, Gayen S (2017) Integrating regression and classification-based QSARs with molecular docking analyses to explore the structure-antiaromatase activity relationships of letrozole-based analogs. Can J Chem 95:1285\u20131295. https:\/\/doi.org\/10.1139\/cjc-2017-0419","journal-title":"Can J Chem"},{"key":"2006_CR43","doi-asserted-by":"crossref","unstructured":"Siden Top, Tang J, Vessieres A, et al (1996) Ferrocenyl hydroxytamoxifen: a prototype for a new range of oestradiol receptor site-directed cytotoxics. Chem Commun, pp 955\u2013956","DOI":"10.1039\/CC9960000955"},{"key":"2006_CR44","doi-asserted-by":"publisher","first-page":"5223","DOI":"10.1002\/chem.200305024","volume":"9","author":"S Top","year":"2003","unstructured":"Top S, Vessi\u00e8res A, Leclercq G et al (2003) Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-depen. Chem A Eur J 9:5223\u20135236. https:\/\/doi.org\/10.1002\/chem.200305024","journal-title":"Chem A Eur J"},{"key":"2006_CR45","doi-asserted-by":"publisher","first-page":"8802","DOI":"10.1039\/c5cs00486a","volume":"44","author":"G Jaouen","year":"2015","unstructured":"Jaouen G, Vessi\u00e8res A, Top S (2015) Ferrocifen type anti cancer drugs. Chem Soc Rev 44:8802\u20138817. https:\/\/doi.org\/10.1039\/c5cs00486a","journal-title":"Chem Soc Rev"},{"key":"2006_CR46","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1039\/c1nj20172g","volume":"35","author":"C Ornelas","year":"2011","unstructured":"Ornelas C (2011) Application of ferrocene and its derivatives in cancer research. New J Chem 35:1973\u20131985. https:\/\/doi.org\/10.1039\/c1nj20172g","journal-title":"New J Chem"},{"key":"2006_CR47","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1002\/anie.200454084","volume":"43","author":"A Krasovskiy","year":"2004","unstructured":"Krasovskiy A, Knochel P (2004) A LiCl-mediated Br\/Mg exchange reaction for the preparation of functionalized aryl- and heteroarylmagnesium compounds from organic bromides. Angew Chemie - Int Ed 43:3333\u20133336. https:\/\/doi.org\/10.1002\/anie.200454084","journal-title":"Angew Chemie - Int Ed"},{"key":"2006_CR48","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0022-328X(00)87079-5","volume":"236","author":"G Neshvad","year":"1982","unstructured":"Neshvad G, Roberts RMG, Silver J (1982) M\u00f6ssbauer studies in ferrocene complexes. IV. Substituent effects in ferrocenyl-carbenium ions. J Organomet Chem 236:237\u2013244","journal-title":"J Organomet Chem"},{"key":"2006_CR49","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1021\/jm0508282","volume":"19","author":"MR Saberi","year":"2006","unstructured":"Saberi MR, Vinh TK, Yee SW et al (2006) Potent CYP19 (Aromatase) 1-[(Benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole Inhibitors: synthesis and biological evaluation Mohammed. J Med Chem 19:1016\u20131022","journal-title":"J Med Chem"},{"key":"2006_CR50","doi-asserted-by":"publisher","DOI":"10.1093\/acprof:oso\/9780198509707.001.0001","volume-title":"The weak hydrogen bond","author":"GR Desiraju","year":"2001","unstructured":"Desiraju GR, Steiner TT (2001) The weak hydrogen bond. Oxford University Press, Berlin"},{"key":"2006_CR51","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1351\/PAC-REC-10-01-02","volume":"83","author":"E Arunan","year":"2011","unstructured":"Arunan E, Desiraju GR, Klein RA et al (2011) Definition of the hydrogen bond (IUPAC Recommendations 2011). Pure Appl Chem 83:1637\u20131641. https:\/\/doi.org\/10.1351\/PAC-REC-10-01-02","journal-title":"Pure Appl Chem"},{"key":"2006_CR52","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1021\/cr9411785","volume":"105","author":"MM Mautner","year":"2005","unstructured":"Mautner MM (2005) The ionic hydrogen bond. Chem Rev 105:213\u2013284. https:\/\/doi.org\/10.1021\/cr9411785","journal-title":"Chem Rev"},{"key":"2006_CR53","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1021\/cg5004484","volume":"14","author":"G Dur\u00e1","year":"2014","unstructured":"Dur\u00e1 G, Carri\u00f3n MC, Jal\u00f3n FA et al (2014) Metal supramolecular frameworks with silver and ditopic Bis(pyrazolyl)methane ligands: effect of the anions and ligand substitution. Cryst Growth Des 14:3510\u20133529. https:\/\/doi.org\/10.1021\/cg5004484","journal-title":"Cryst Growth Des"},{"key":"2006_CR54","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1021\/cg201677s","volume":"12","author":"MC Carri\u00f3n","year":"2012","unstructured":"Carri\u00f3n MC, Dur\u00e1 G, Jal\u00f3n FA et al (2012) Polynuclear complexes containing ditopic bispyrazolylmethane ligands. Influence of metal geometry and supramolecular interactions. Cryst Growth Des 12:1952\u20131969. https:\/\/doi.org\/10.1021\/cg201677s","journal-title":"Cryst Growth Des"},{"key":"2006_CR55","doi-asserted-by":"publisher","first-page":"11287","DOI":"10.1158\/0008-5472.CAN-05-2737","volume":"65","author":"OK Weinberg","year":"2005","unstructured":"Weinberg OK, Marquez-Garban DC, Fishbein MC et al (2005) Aromatase inhibitors in human lung cancer therapy. Cancer Res 65:11287\u201311291. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-2737","journal-title":"Cancer Res"},{"key":"2006_CR56","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0960-0760(93)90289-9","volume":"46","author":"D Zhou","year":"1993","unstructured":"Zhou D, Wang J, Chen E et al (1993) Aromatase GENE is amplified in MCF-7 human breast cancer cells. J Steroid Biochem Molec Biol 46:147\u2013153","journal-title":"J Steroid Biochem Molec Biol"},{"key":"2006_CR57","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1158\/1078-0432.CCR-14-0816","volume":"21","author":"T VanArsdale","year":"2015","unstructured":"VanArsdale T, Boshoff C, Arndt KT, Abraham RT (2015) Molecular pathways: targeting the cyclin D-CDK4\/6 axis for cancer treatment. Clin Cancer Res 21:2905\u20132910. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-0816","journal-title":"Clin Cancer Res"},{"key":"2006_CR58","unstructured":"https:\/\/www.rcsb.org\/structure\/3EQM. Accessed 21 Jan 2020"},{"key":"2006_CR59","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1124\/dmd.30.3.314","volume":"30","author":"W Zhang","year":"2002","unstructured":"Zhang W, Ramamoorthy Y, Kilicarslan T et al (2002) Inhibition of cytochromes P450 by antifungal imidazole derivatives. Drug Metab Dispos 30:314\u2013318. https:\/\/doi.org\/10.1124\/dmd.30.3.314","journal-title":"Drug Metab Dispos"},{"key":"2006_CR60","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.cbi.2011.05.001","volume":"193","author":"JP Jones","year":"2011","unstructured":"Jones JP, Joswig-Jones CA, Hebner M et al (2011) The effects of nitrogen-heme-iron coordination on substrate affinities for cytochrome P450 2E1. Chem Biol Interact 193:50\u201356. https:\/\/doi.org\/10.1016\/j.cbi.2011.05.001","journal-title":"Chem Biol Interact"},{"key":"2006_CR61","doi-asserted-by":"publisher","first-page":"6244","DOI":"10.1021\/acsomega.7b01102","volume":"2","author":"H Cumming","year":"2017","unstructured":"Cumming H, R\u00fccker C (2017) Octanol-water partition coefficient measurement by a simple 1H NMR method. ACS Omega 2:6244\u20136249. https:\/\/doi.org\/10.1021\/acsomega.7b01102","journal-title":"ACS Omega"},{"key":"2006_CR62","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1023\/A:1012188625088","volume":"14","author":"K Palm","year":"1997","unstructured":"Palm K, Stenberg P, Luthman K, Artursson P (1997) Polar molecular surface properties predict the intestinal absorption of drugs in humans. Pharm Res 14:568\u2013571","journal-title":"Pharm Res"},{"key":"2006_CR63","doi-asserted-by":"publisher","first-page":"15711","DOI":"10.1073\/pnas.0704459104","volume":"104","author":"A Ghosh","year":"2007","unstructured":"Ghosh A, Vishveshwara S (2007) A study of communication pathways in methionyl-tRNA synthetase by molecular dynamics simulations and structure network analysis. Proc Natl Acad Sci U S A 104:15711\u201315716. https:\/\/doi.org\/10.1073\/pnas.0704459104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2006_CR64","unstructured":"SAINT v8.37, Bruker-AXS (2016) APEX3 v2016.1.0. Madison, Wisconsin, USA."},{"key":"2006_CR65","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1107\/S1600576714022985","volume":"48","author":"L Krause","year":"2015","unstructured":"Krause L, Herbst-Irmer R, SADABS et al (2015) SADABS. J Appl Crystallogr 48:3","journal-title":"J Appl Crystallogr"},{"key":"2006_CR66","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1107\/S0021889812029111","volume":"45","author":"LJ Farrugia","year":"2012","unstructured":"Farrugia LJ (2012) WinGX and ORTEP for Windows: an update. J Appl Cryst 45:849\u2013854. https:\/\/doi.org\/10.1107\/S0021889812029111","journal-title":"J Appl Cryst"},{"key":"2006_CR67","unstructured":"Sheldrick GM (2014) SHELX-2014, Progr. Cryst. Struct. Refinement, Univ G\u00f6ttingen, G\u00f6ttingen, Ger"},{"key":"2006_CR68","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W et al (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30:2785\u20132791. https:\/\/doi.org\/10.1002\/jcc","journal-title":"J Comput Chem"},{"key":"2006_CR69","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/prot.20251","volume":"57","author":"E Krieger","year":"2004","unstructured":"Krieger E, Darden T, Nabuurs SB et al (2004) Making optimal use of empirical energy functions: force-field parameterization in crystal space. Proteins Struct Funct Bioinforma 57:678\u2013683. https:\/\/doi.org\/10.1002\/prot.20251","journal-title":"Proteins Struct Funct Bioinforma"},{"key":"2006_CR70","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/prot.10104","volume":"47","author":"E Krieger","year":"2002","unstructured":"Krieger E, Koraimann G, Vriend G (2002) Increasing the precision of comparative models with YASARA NOVA\u2014a self-parameterizing force field. Proteins Struct Funct Genet 47:393\u2013402. https:\/\/doi.org\/10.1002\/prot.10104","journal-title":"Proteins Struct Funct Genet"}],"container-title":["JBIC Journal of Biological Inorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00775-023-02006-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00775-023-02006-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00775-023-02006-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T09:06:48Z","timestamp":1691658408000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00775-023-02006-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,17]]},"references-count":70,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["2006"],"URL":"https:\/\/doi.org\/10.1007\/s00775-023-02006-0","relation":{},"ISSN":["1432-1327"],"issn-type":[{"value":"1432-1327","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,17]]},"assertion":[{"value":"24 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}